Ianthus Capital Holdings Inc
CNSX:IAN
Net Margin
Ianthus Capital Holdings Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
CA |
I
|
Ianthus Capital Holdings Inc
CNSX:IAN
|
33.7m CAD |
7%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
754.1B USD |
23%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
367.2B USD |
24%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK |
35%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
208.9B CHF |
14%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
188.5B CHF |
24%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
157.3B GBP |
14%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
199.7B USD |
27%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
-126%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
137.9B USD |
13%
|
Ianthus Capital Holdings Inc
Glance View
iAnthus Capital Holdings, Inc. engages in the provision of financing licensed cannabis cultivators, processors, and dispensaries. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2016-09-07. The Company, through its subsidiaries, owns and operates approximately 31 dispensaries and 10 cultivation and/or processing facilities in the United States. In addition, it distributes cannabis and CBD products to over 200 dispensaries and CBD products to over 2,300 retail locations throughout the United States. Its Cannabis products include biomass, products containing biomass, such as pre-rolls, cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils and tinctures. Its CBD products include topical creams, tinctures and sprays and products designed for beauty and skincare.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Ianthus Capital Holdings Inc's most recent financial statements, the company has Net Margin of 7%.